

Aneuploidy is associated with different human diseases including cancer. However, different cell types appear to respond differently to aneuploidy, either by promoting tumorigenesis or causing cell death. We set out to study the behavior of adult Drosophila melanogaster intestinal stem cells (ISCs) after induction of chromosome missegregation either by abrogation of the spindle assembly checkpoint or through kinetochore disruption or centrosome amplification. These conditions induce moderate levels of aneuploidy in ISCs, and we find no evidence of apoptosis. Instead, we observe a significant accumulation of ISCs associated with increased stem cell proliferation and an excess of enteroendocrine cells. Moreover, aneuploidy causes up-regulation of the JNK pathway throughout the posterior midgut, and specific inhibition of JNK signaling in ISCs is sufficient to prevent dysplasia. Our findings highlight the importance of understanding the behavior of different stem cell populations to aneuploidy and how these can act as reservoirs for genomic alterations that can lead to tissue pathologies. © 2018 Resende et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
| EMTREE drug terms: | stress activated protein kinase |
|---|---|
| EMTREE medical terms: | adultaneuploidyanimal cellanimal experimentanimal modelanimal tissueapoptosisArticlecell expansioncell functioncell migrationcell proliferationcentrosomechromosome segregationcontrolled studyDrosophila melanogasterdysplasiaenteroendocrine cellenzyme inhibitionfemalegene mutationgut dysplasiaintestinal stem cellkinetochoreM phase cell cycle checkpointnonhumanpriority journalsignal transductiontissue injuryupregulation |
stress activated protein kinase, 155215-87-5
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fundação Portugal Telecom | ||
| Fundação para a Ciência e a Tecnologia See opportunities | PTDC/BEX-BCM/1921/2014 | |
| China National Funds for Distinguished Young Scientists | ||
| European Regional Development Fund |
This article is a result of the project Norte Portugal Regional Operational Program (NORTE 2020) Norte-01-0145-FEDER-000029 – Advancing Cancer Research: From basic knowledge to application, under the PORTUGAL 2020 Partnership Agreement through the European Regional Development Fund, and it is also funded by National Funds through Fundação para a Ciência e a Tecnologia under the project PTDC/BEX-BCM/1921/2014. The authors declare no competing financial interests.
Resende, L.P.; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal;
© Copyright 2018 Elsevier B.V., All rights reserved.